ArticleJournal of clinical medicine2020

Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbitopathy: National Multicenter Observational Study of 48 Patients.

Lara Sánchez-Bilbao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.